Table 2.
Stage | Suggested upper limit of target IOP (Modified based on longevity, QOL, & risk factors for progression) | Evidence |
---|---|---|
Suspect in whom a clinical decision is made regarding treatment | 24 mmHg with at least | OHTS |
20% reduction from baseline | EGPS | |
Early | 20 mmHg with at least | EMGTS |
25% reduction from baseline | CIGTS | |
Moderate | 17 mmHg with at least | CNTGS |
30% reduction from baseline | AGIS | |
Advanced | 14 mmHg with at least | AGIS |
30% reduction from baseline | Odberg |
AGIS = Advanced Glaucoma Intervention Study; CIGTS = Collaborative Initial Glaucoma Treatment Study; CNTGS = Collaborative Normal Tension Glaucoma Study; EGPS = European Glaucoma Prevention Study; EMGTS = Early Manifest Glaucoma Treatment Study; OHTS = Ocular Hypertension Treatment Study.